Does zinc deficiency decrease circulating T3 by impairing thyroid hormone metabolism?

An analysis of the evidence regarding the role of zinc in thyroid hormone metabolism and its impact on circulating T3 levels yields the following findings:

Clinical and effectiveness evidence

• Impact of deficiency and supplementation: Research indicates that zinc deficiency can impair the peripheral conversion of thyroxine (T4) to the biologically active triiodothyronine (T3), leading to reduced circulating T3 levels. Small clinical studies and animal models support this relationship. For example, in a study of zinc-deficient patients, oral zinc supplementation successfully altered thyroid hormone metabolism, showing improved T4-to-T3 conversion rates.
• Replete vs. deficient individuals: The therapeutic benefit of zinc supplementation on thyroid hormones is primarily observed in individuals with an active, baseline zinc deficiency. In healthy, zinc-replete individuals, acute zinc administration does not result in significant changes in circulating thyroid hormone levels. Furthermore, a randomized controlled trial in pediatric patients with autoimmune thyroiditis did not show significant changes in free T3 levels following zinc supplementation, though it suggested a stabilizing effect on thyroid medication requirements.

Mechanistic explanations

• Thyroid hormone receptor structure: Zinc is directly required for the transcriptional activity of thyroid hormone receptors (TRs). These nuclear receptors contain "zinc-finger" DNA-binding domains that rely on zinc for proper folding and binding to thyroid response elements on DNA. Without adequate zinc, cellular responsiveness to T3 is compromised, even if circulating hormone levels are normal.
• Support for deiodination: While zinc does not act as a direct catalytic cofactor for deiodinase enzymes (which are selenoproteins dependent on selenium), it is indispensable for the broader cellular environment that supports deiodination. Zinc is required for general protein translation and ribosomal function, which indirectly regulates the synthesis of deiodinases (D1, D2, and D3).
• Systemic regulation: Zinc supports the hypothalamic-pituitary-thyroid (HPT) axis and growth hormone signaling, which are upstream regulators of thyroid hormone production. It also plays a key role in antioxidant defense (via copper/zinc-superoxide dismutase) and immune regulation, protecting deiodinase enzymes and thyroid tissues from oxidative stress and inflammation.

Bottom line

The claim that zinc is required for normal thyroid hormone metabolism and that zinc deficiency can decrease circulating T3 is fully supported by scientific evidence. Zinc plays a crucial structural role in thyroid hormone receptors and indirectly supports the synthesis and function of the deiodinase enzymes that convert T4 to T3. Identifying and correcting a zinc deficiency is a clinically sound approach to optimizing thyroid hormone pathways, particularly for individuals experiencing suboptimal peripheral conversion.